With a market cap of $442 billion and annual revenues exceeding $94 billion, Johnson & Johnson (JNJ) is one of the world's largest and most diverse healthcare companies. The company operates under three divisions: Pharmaceutical, Medical Devices, and Consumer. However, in November of this year, JNJ announced plans to spin off the consumer division. The Pharmaceutical and Medical Devices segments represent about 80% of sales and drive the majority of cash flows for the firm. The pharmaceutical portfolio focuses on immunology, oncology, neurology, pulmonary, cardiology, and metabolic diseases. The medical device segment focuses on orthopedics, surgery tools, and vision care.
https://www.tipranks.com/news/article/jnj-stock-spinoff-sales-growth-will-create-value?utm_source=advfn.com&utm_medium=referral